Real world outcomes with idecabtagene vicleucel (ide-cel) CAR-T cell therapy for relapsed/refractory multiple myeloma Meeting Abstract
| Authors: | Sidana, S.; Ahmed, N.; Akhtar, O. S.; Heim, M.; Brazauskas, R.; Hansen, D. K.; Ferreri, C.; Freeman, C. L. L.; Afrough, A.; Anderson, L. D. Jr; Dhakal, B.; Dhanda, D.; Gowda, L.; Hashmi, H.; Harrison, M.; Kitali, A.; Mirza, S.; Patel, J.; Patwardhan, P.; Usmani, S. Z.; Patel, K. K.; Ganguly, S.; Pasquini, M. |
| Abstract Title: | Real world outcomes with idecabtagene vicleucel (ide-cel) CAR-T cell therapy for relapsed/refractory multiple myeloma |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 1027 |
| Language: | English |
| ACCESSION: | WOS:001159306704051 |
| DOI: | 10.1182/blood-2023-181762 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
